|Phone||31 24 352 96 33|
|Private Equity, 3/2013 |
Innovation & Investment Fund Gelderlandt
InteRNA Technologies secures additional equity financing to progress lead program for melanoma treatment
Nijmegen/Utrecht (the Netherlands) – InteRNA Technologies B.V., a biopharma company engaged in the development of microRNA (miRNA)-based therapeutics for oncology, announces today the closing of an equity financing round. New investors participating in this round include the ‘Innovation & Investment Fund Gelderland’, managed by PPM Oost and several business angels.